Stockert is a leading developer and manufacturer of medical technology products in the field of electrophysiology. The company is the global leader for high frequency ablation systems to treat cardiac arrhythmia. Stockert has a global market share of >30% and an installed base of more than 6,500 systems in over 165 countries. Every year, c. 2.5m treatments are performed with Stockert products.
Stockert owns comprehensive international certificates complying with current medical technology regulations and counts the world’s leading med-tech OEMs among its customers. For 35 years, the company distinguished itself through its continuously strong innovative power and the reliability of its products, which ensure the highest level of patient safety. This is ensured by the management’s clear focus on quality and innovation, as well as Stockert’s experienced and excellent team.
"We develop and produce innovative, safe and user-friendly solutions for minimally invasive therapy methods to improve the quality of life of patients and their families."
Product: Medical technology solutions for minimally invasive therapies
Employees: c. 75
Headquarter:Freiburg im Breisgau, Germany
Status: Active investmentwww.stockert.de